{"url_path":"/sec/skin/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1818093/0001628280-26-037340-index.html","accession_number":"0001628280-26-037340","cik":"0001818093","ticker":"SKIN","issuer_name":"SkinHealth Systems Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1818093/0001628280-26-037340-index.html","primary_entity_key":"0001818093","primary_entity_name":"SkinHealth Systems Inc."},"word_count":89,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nDescription\n\n[10.1](ex101-separationagreementx.htm)\n\n[Severance and General Release Agreement, entered into May 15, 2026, by and among Hydrafacial LLC, SkinHealth Systems Inc., and Ronald Menezes](ex101-separationagreementx.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDated: May 21, 2026SkinHealth Systems Inc.\n\nBy:/s/ Michael Monahan\n\nName:Michael Monahan\n\nTitle:Chief Financial Officer"}